{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-400087","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2026-09-24T10:01:32+00:00","discovered_at":"2026-09-24T10:05:00.486341+00:00","generated_at":"2026-09-24T10:05:13.127353+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Jaguar Health issues 547,898 shares to cut $5.05M of 2025 Streeterville note","bullets":["Exchanged 547,898 common shares for $5,049,909 reduction in $10.81M secured note to Streeterville Capital.","Shares issued under Section 3(a)(9); no cash paid, shares to become free-trading after Rule 144 holding period tacking.","Post-exchange share count ~1,281,867; issuance adds ~74.6% to prior outstanding stock.","Note reduction represents ~47% of original principal; remaining balance continues under existing terms.","CEO Lisa Conte signed; Streeterville receives unrestricted shares via DWAC delivery."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-400087","json":"https://secwatch.observer/filing/0001193125-26-400087.json","markdown":"https://secwatch.observer/filing/0001193125-26-400087.md","text":"https://secwatch.observer/filing/0001193125-26-400087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526400087/0001193125-26-400087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526400087/d161376d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-24T10:05:13.127353+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}